Annual Shareholders Equity
$36.83 M
-$68.82 M-65.14%
December 31, 2023
Summary
- As of February 8, 2025, XLO annual stockholders equity is $36.83 million, with the most recent change of -$68.82 million (-65.14%) on December 31, 2023.
- During the last 3 years, XLO annual shareholders equity has risen by +$120.11 million (+144.22%).
- XLO annual shareholders equity is now -80.14% below its all-time high of $185.43 million, reached on December 31, 2021.
Performance
XLO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$20.97 M
-$12.44 M-37.23%
September 30, 2024
Summary
- As of February 8, 2025, XLO quarterly stockholders equity is $20.97 million, with the most recent change of -$12.44 million (-37.23%) on September 30, 2024.
- Over the past year, XLO quarterly shareholders equity has dropped by -$15.85 million (-43.05%).
- XLO quarterly shareholders equity is now -88.69% below its all-time high of $185.43 million, reached on December 31, 2021.
Performance
XLO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
XLO Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -65.1% | -43.0% |
| 3 y3 years | +144.2% | -43.0% |
| 5 y5 years | +2435.1% | -43.0% |
XLO Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -80.1% | at low | -88.7% | at low |
| 5 y | 5-year | -80.1% | +144.2% | -88.7% | +115.4% |
| alltime | all time | -80.1% | +144.2% | -88.7% | +115.4% |
Xilio Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $20.97 M(-37.2%) |
| Jun 2024 | - | $33.42 M(+29.7%) |
| Mar 2024 | - | $25.77 M(-30.0%) |
| Dec 2023 | $36.83 M(-65.1%) | $36.83 M(-29.9%) |
| Sep 2023 | - | $52.50 M(-22.1%) |
| Jun 2023 | - | $67.38 M(-20.5%) |
| Mar 2023 | - | $84.79 M(-19.7%) |
| Dec 2022 | $105.65 M | $105.65 M(-16.4%) |
| Sep 2022 | - | $126.30 M(-12.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $144.22 M(-13.2%) |
| Mar 2022 | - | $166.12 M(-10.4%) |
| Dec 2021 | $185.43 M(-322.6%) | $185.43 M(-235.9%) |
| Sep 2021 | - | -$136.46 M(+12.5%) |
| Jun 2021 | - | -$121.31 M(+45.7%) |
| Dec 2020 | -$83.29 M(+182.1%) | -$83.29 M |
| Dec 2019 | -$29.52 M(-2132.3%) | - |
| Dec 2018 | $1.45 M(-36.2%) | - |
| Dec 2017 | $2.28 M(-7.2%) | - |
| Dec 2016 | $2.45 M | - |
FAQ
- What is Xilio Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Xilio Therapeutics?
- What is Xilio Therapeutics annual shareholders equity year-on-year change?
- What is Xilio Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Xilio Therapeutics?
- What is Xilio Therapeutics quarterly shareholders equity year-on-year change?
What is Xilio Therapeutics annual stockholders equity?
The current annual shareholders equity of XLO is $36.83 M
What is the all time high annual shareholders equity for Xilio Therapeutics?
Xilio Therapeutics all-time high annual stockholders equity is $185.43 M
What is Xilio Therapeutics annual shareholders equity year-on-year change?
Over the past year, XLO annual stockholders equity has changed by -$68.82 M (-65.14%)
What is Xilio Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of XLO is $20.97 M
What is the all time high quarterly shareholders equity for Xilio Therapeutics?
Xilio Therapeutics all-time high quarterly stockholders equity is $185.43 M
What is Xilio Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, XLO quarterly stockholders equity has changed by -$15.85 M (-43.05%)